» Articles » PMID: 14592342

Validation of the International Restless Legs Syndrome Study Group Rating Scale for Restless Legs Syndrome

Overview
Journal Sleep Med
Specialties Neurology
Psychiatry
Date 2003 Nov 1
PMID 14592342
Citations 453
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is a need for an easily administered instrument which can be applied to all patients with restless legs syndrome (RLS) to measure disease severity for clinical assessment, research, or therapeutic trials. The pathophysiology of RLS is not clear and no objective measure so far devised can apply to all patients or accurately reflect severity. Moreover, RLS is primarily a subjective disorder. Therefore, a subjective scale is at present the optimal instrument to meet this need.

Methods: Twenty centers from six countries participated in an initial reliability and validation study of a rating scale for the severity of RLS designed by the International RLS study group (IRLSSG). A ten-question scale was developed on the basis of repeated expert evaluation of potential items. This scale, the IRLSSG rating scale (IRLS), was administered to 196 RLS patients, most on some medication, and 209 control subjects.

Results: The IRLS was found to have high levels of internal consistency, inter-examiner reliability, test-retest reliability over a 2-4 week period, and convergent validity. It also demonstrated criterion validity when tested against the current criterion of a clinical global impression and readily discriminated patient from control groups. The scale was dominated by a single severity factor that explained at least 59% of the pooled item variance.

Conclusions: This scale meets performance criteria for a brief, patient completed instrument that can be used to assess RLS severity for purposes of clinical assessment, research, or therapeutic trials. It supports a finding that RLS is a relatively uniform disorder in which the severity of the basic symptoms is strongly related to their impact on the patient's life. In future studies, the IRLS should be tested against objective measures of RLS severity and its sensitivity should be studied as RLS severity is systematically manipulated by therapeutic interventions.

Citing Articles

The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine.

Suzuki K, Suzuki S, Fujita H, Kobayashi S, Shioda M, Hida R J Headache Pain. 2025; 26(1):36.

PMID: 39972460 PMC: 11837639. DOI: 10.1186/s10194-025-01976-7.


Exploring the Psychological and Physiological Insights Through Digital Phenotyping by Analyzing the Discrepancies Between Subjective Insomnia Severity and Activity-Based Objective Sleep Measures: Observational Cohort Study.

Yeom J, Kim H, Pack S, Lee H, Cheong T, Cho C JMIR Ment Health. 2025; 12:e67478.

PMID: 39869900 PMC: 11811666. DOI: 10.2196/67478.


Simultaneous evaluation of restless leg syndrome, neuropathic pain, disease activity, and quality of life in patients with Takayasu arteritis: a cross-sectional study.

Kokoglu E, Kiziltepe M, Kaplan H, Sas S, Denizhan T, Senel A Sci Rep. 2025; 15(1):3158.

PMID: 39856134 PMC: 11760883. DOI: 10.1038/s41598-024-83110-2.


Relationship between sleep disorders and information processing speed in multiple sclerosis.

Ashtari F, Ghalamkari A, Naghavi S, Pourmohammadi A, Adibi I, Karimi Z Clinics (Sao Paulo). 2025; 80:100574.

PMID: 39847814 PMC: 11795377. DOI: 10.1016/j.clinsp.2024.100574.


Clinical impact of restless legs syndrome in patients with migraine: a 12-year, single-center, longitudinal study.

Suzuki K, Suzuki S, Haruyama Y, Fujita H, Hirata K Sleep Biol Rhythms. 2025; 23(1):21-27.

PMID: 39801933 PMC: 11718025. DOI: 10.1007/s41105-024-00547-8.